Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

PAHO concludes 62nd Directing Council with Strategic Plan 2026-2031 for healthier Americas

6

Oct 2025

PAHO concludes 62nd Directing Council with Strategic Plan 2026-2031 for healthier Americas

The 62nd Directing Council of the Pan American Health Organization (PAHO) concluded today, setting a bold agenda to address pressing health challenges across the Americas through the approval of the PAHO Strategic Plan 2026-2031 and key resolutions aimed at expanding access to high-cost high price health technologies, and preventing and controlling noncommunicable diseases (NCDs).

PAHO Director calls for stronger cooperation in health financing and security

6

Oct 2025

PAHO Director calls for stronger cooperation in health financing and security

Pan American Health Organization (PAHO) Director Dr. Jarbas Barbosa met on Wednesday October 1 with members of the Council of the Americas' Healthcare Series leadership group and with health authorities from Argentina, Brazil, the Dominican Republic, Guyana, and Panama to advocate for stronger cooperation in health financing and security.

PAHO and Haitian government unite to advance health equity and care

6

Oct 2025

PAHO and Haitian government unite to advance health equity and care

The Pan American Health Organization/World Health Organization (PAHO/WHO) and the Government of Haiti signed the 2026-2028 Country Cooperation Strategy (CCS), the first cooperation framework of its kind between the two, reaffirming their shared commitment to strengthening Haiti's health system and improving health outcomes for all.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.